A recent study by Zhang et al. showed that using comparative bioinformatic analyses of various types of prostate cancer, an enrichment of a MYC-N-PARP-DDR (DNA damage response) pathway in NPEC was observed [683]. The gene discussed is MYC; the disease is prostate carcinoma.